Relapse B Acute Lymphoblastic Leukemia
2 clinical trials · Condition
◉ Watch Relapse B Acute Lymphoblastic Leukemia
| Record | Firm | Date |
|---|---|---|
| Safety and Efficacy of Dual Specificity CD19 and CD22 CAR-T Cell Immunotherapy in R/R Acute B Lymphoblastic Leukemia (NCT04094766) | Second Affiliated Hospital of Xi'an Jiaotong University | 2017-08-01 |
Track Relapse B Acute Lymphoblastic Leukemia automatically
Every clearance here is in the API, with alerts when new ones post.